🔎 Trials Near Me

Utama › Neuroblastoma › New York › New York City

Kajian klinikal Neuroblastoma di New York City, NY

10 kajian untuk Neuroblastoma sedang mencari peserta di lokasi dalam dan sekitar New York City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Mengambil pesertaKajian pemerhatian
  • Memorial Sloan Kettering Cancer Center, New York
Semua umur · Semua jantina · Dikemas kini 5 Okt 2026 · NCT00588068

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Mengambil pesertaFasa 3
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Sehingga umur 30 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06172296

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
  • Memorial Sloan Kettering Cancer Center, New York
Semua umur · Semua jantina · Dikemas kini 30 Sep 2026 · NCT04936529

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Mengambil pesertaFasa 1/2
  • Memorial Sloan Kettering Cancer Center ( Site 1010), New York
6 Months – 25 Years · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06395103

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Cancer Center, New York
18 Months – 19 Years · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT06528496

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Mengambil pesertaFasa 3
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
365 Days – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Mengambil pesertaFasa 1/2
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
12 Months – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

Mengambil pesertaFasa 1/2
  • Memorial Sloan Kettering Kids, New York
Umur 2 hingga 21 · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05642455

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Semua umur · Semua jantina · Dikemas kini 28 Jul 2026 · NCT06057948

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Cancer Center, New York
Umur 1 ke atas · Semua jantina · Dikemas kini 29 Mei 2026 · NCT00107289

Kajian Neuroblastoma di bandar lain

Kajian lain di New York City

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.